ARTICLE | Clinical News

IV ANAVEX 2-73: Completed Phase IIa enrollment

November 2, 2015 8:00 AM UTC

Anavex completed enrollment of 32 patients with mild to moderate AD in an open-label, crossover, Australian Phase IIa trial to evaluate ANAVEX 2-73. In part A of the trial, patients are receiving a 30...